Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

Author(s):
Anninga, J.K.; Gelderblom, H.; Fiocco, M.; Kroep, J.R.; Taminiau, A.H.M.; Hogendoorn, P.C.W. (0000-0002-1513-8104); Egeler, R.M.
Published
2011
Publication type
Article / Letter to editor
Bone neoplasmBoneOsteosarcomaChemotherapyReviewAdriamycinCisplatinIfosfamideMethotrexatePathological response
Date issued
2011-11-30
Language
English
Is part of
European Journal of Cancer (2011), Vol. 47, no. 16, p. 2431-2445
hdl
1887/109097
doi
10.1016/j.ejca.2011.05.030